Opioid Studies Mark Slowdown in Abuse, But Work Remains

... the U.S. Department of Veterans Affairs, which has done extensive work on chronic pain in veterans. On Jan. 26, Stamford, Conn.-based Purdue Pharma announced its U.S. launch of Hysingla ER (hydrocodone bitartrate) extended-release tablets CII, which ...

http://ift.tt/1yOBvIp